Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,556,906
-$32,846 QoQ
Shares Held
12,116
-8.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#1,768
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GARRISON POINT ADVISORS, LLC holds $11,648,529 across 8 Drug Manufacturers - General names. MRK ranks #4 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,613 | $4,219,203 | |
| 2 | AMGN |
Amgen Inc
|
5,460 | $1,977,175 | |
| 3 | NVO |
Novo Nordisk A S
|
33,268 | $1,594,867 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
12,116 | $1,556,906 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
15,198 | $875,708 | |
| 6 | ABBV |
AbbVie Inc.
|
3,016 | $758,946 | |
| 7 | LLY |
ELI LILLY & Co
|
345 | $413,803 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,994 | $251,921 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,556,906 | 12,116 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,589,752 | 13,216 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,506,796 | 14,315 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,379,725 | 16,439 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,400,577 | 17,693 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,588,033 | 17,692 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,850,427 | 18,601 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $704,980 | 6,208 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $842,830 | 6,808 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $957,825 | 7,259 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $808,165 | 7,413 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $776,243 | 7,540 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $881,464 | 7,639 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $834,948 | 7,848 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $584,706 | 5,270 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $470,990 | 5,469 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $498,608 | 5,469 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $448,649 | 5,468 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $418,990 | 5,467 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $404,166 | 5,381 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $418,402 | 5,380 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $404,645 | 5,249 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $407,036 | 4,976 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $393,349 | 4,742 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $366,621 | 4,741 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $367,849 | 4,781 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||